A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro - Murakami, K; Kobayashi, Y; Uehara, S; Suzuki, T; Koide, M; Yamashita, T; Nakamura, M; Takahashi, N; Kato, H; Udagawa, N; Nakamura, Y (PLoS One, 2017)